Literature DB >> 9638871

Susceptibility of the anaerobic gram-negative non-sporulating rod, Bilophila wadsworthia to beta-lactams, beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and quinolones.

U K Schumacher1, B Single.   

Abstract

The susceptibility of eighty-seven strain of Bilophila wadsworthia to five beta-lactams, two beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and two quinolones was determined. Tests were performed by the modified reference agar dilution technique using triphenyltetrazolium chloride for endpoint reading. The test strains showed a reduced susceptibility to the beta-lactams, penicillin G (MIC90 4 micrograms/ml), ampicillin (MIC90 32 micrograms/ml), piperacillin (MIC90 64 micrograms/ml), cephalothin (MIC90 2 micrograms/ml and cefotaxim (MIC90 4 micrograms/ml). The activity of ampicillin was increased by addition of the beta-lactamase inhibitor, sulbactam (MIC90 2 micrograms/ml), as was the activity of piperacillin by the addition of tazobactam (MIC90 4 micrograms/ml) 90.8% of the strains were found to produce beta-lactamase by the nitrocefin tube method. All strains were shown to be highly susceptible to meropenem, metronidazole and clindamycin (MICs < or = 1 microgram/ml). Sparfloxacin (MIC90 1 microgram/ml) and ciprofloxacin (MIC90 0.5 microgram/ml) were found to be active against most of the strains tested.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638871     DOI: 10.1016/s0934-8840(98)80179-5

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  2 in total

1.  Comparison of effects of medium composition and atmospheric conditions on detection of Bilophila wadsworthia beta-lactamase by cefinase and cefinase plus methods.

Authors:  P H Summanen
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics.

Authors:  Abdelaziz El Houari; Florine Ecale; Anne Mercier; Stéphanie Crapart; Jérôme Laparre; Baptiste Soulard; Manilduth Ramnath; Jean-Marc Berjeaud; Marie-Hélène Rodier; Alexandre Crépin
Journal:  Front Microbiol       Date:  2022-04-12       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.